A detailed history of Green Alpha Advisors, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 64,213 shares of PACB stock, worth $125,215. This represents 0.09% of its overall portfolio holdings.

Number of Shares
64,213
Previous 34,096 88.33%
Holding current value
$125,215
Previous $46,000 136.96%
% of portfolio
0.09%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$1.2 - $2.17 $36,140 - $65,353
30,117 Added 88.33%
64,213 $109,000
Q2 2024

Aug 13, 2024

SELL
$1.36 - $3.65 $21,557 - $57,856
-15,851 Reduced 31.74%
34,096 $46,000
Q1 2024

Apr 09, 2024

BUY
$3.52 - $9.59 $29,962 - $81,630
8,512 Added 20.54%
49,947 $187,000
Q4 2023

Jan 04, 2024

SELL
$5.97 - $10.36 $195,881 - $339,921
-32,811 Reduced 44.19%
41,435 $406,000
Q3 2023

Oct 10, 2023

SELL
$8.23 - $13.93 $303,398 - $513,529
-36,865 Reduced 33.18%
74,246 $619,000
Q2 2023

Jul 06, 2023

BUY
$9.97 - $14.05 $61,973 - $87,334
6,216 Added 5.93%
111,111 $1.48 Million
Q1 2023

Apr 06, 2023

BUY
$7.94 - $12.02 $3,469 - $5,252
437 Added 0.42%
104,895 $1.21 Million
Q4 2022

Jan 12, 2023

SELL
$5.67 - $11.2 $1,769 - $3,494
-312 Reduced 0.3%
104,458 $0
Q3 2022

Oct 14, 2022

SELL
$3.93 - $8.57 $1.25 Million - $2.73 Million
-318,066 Reduced 75.22%
104,770 $608,000
Q2 2022

Jul 08, 2022

BUY
$4.02 - $10.43 $1.56 Million - $4.04 Million
387,032 Added 1080.97%
422,836 $1.87 Million
Q1 2022

Apr 19, 2022

BUY
$8.43 - $20.9 $65,391 - $162,121
7,757 Added 27.66%
35,804 $326,000
Q4 2021

Jan 12, 2022

BUY
$19.26 - $30.08 $54,274 - $84,765
2,818 Added 11.17%
28,047 $574,000
Q3 2021

Oct 12, 2021

BUY
$24.86 - $35.02 $123,057 - $173,349
4,950 Added 24.41%
25,229 $645,000
Q2 2021

Jul 22, 2021

BUY
$22.3 - $36.02 $452,221 - $730,449
20,279 New
20,279 $709,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Green Alpha Advisors, LLC Portfolio

Follow Green Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.